"Optimizing Psychiatric Care through Pharmacogenomics: An Evidence-Base" by Marc Boulanger

Date of Award

Spring 5-24-2025

Document Type

Doctor of Nursing Practice Final Manuscript

Degree Name

Doctor of Nursing Practice

Department

Nursing

First Advisor

Autumn Roque, DNP, APRN, PMHNP-BC

Abstract

Objective: This scholarly project aimed to enhance psychiatric providers' competency, confidence, and knowledge in the PHASER pharmacogenomic (PGx) testing program at the VA San Diego Healthcare System.

Background: PGx testing enhances psychiatric care by enabling precise medication management tailored to a patient’s genetic profile, improving treatment effectiveness and reducing adverse drug reactions. Despite demonstrated clinical utility, adoption of PGx remains limited due to provider knowledge gaps. This project addresses these gaps through targeted education.

Methods: Two educational modules, developed with input from the PHASER site-lead, aimed to enhance provider knowledge and confidence in PGx. Module one introduced the PHASER program and PGx applications, while the second utilized case studies to illustrate PGx’s clinical utility. Pre- and post-assessments measured provider knowledge, competence, and confidence, while PGx test utilization data assessed the initiative's impact.

Results: Analysis demonstrated improved provider competence and confidence in PGx application. Statistically significant competence gains occurred in PGx principles (p = 0.040), informed consent (p = 0.026), and ethical considerations (p = 0.011). Providers reported significantly greater confidence in applying PGx testing (p = 0.018) and communicating results (p = 0.028); however, improvements in managing concerns did not reach significance (p = 0.16). Knowledge scores increased from 86 to 94 percent, reflecting a 7.33% improvement (p = 0.039).

Conclusion: This project demonstrated the effectiveness of targeted education in enhancing PGx adoption in psychiatric care. These findings also highlight the intervention’s effectiveness in enhancing provider confidence, competence, and knowledge in PGx application.

Keywords: Pharmacogenomics, major depressive disorder, clinical psychiatry, PGx testing, Veterans Health Administration, PHASER, healthcare provider education, quality improvement

Share

COinS